Cancer cells, instead, use S100A11 for their growth advantage through the secretion of S100A11 into the outside fluid, which stimulates receptors for advanced glycation end product (RAGE) on cancer cells in an autocrine manner (Sakaguchi et al. 2008). This evidence concerns the gene S100A11 and cancer.